A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer
about
A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A phase I study of nimotuzumab ...... ced non-small-cell lung cancer
@ast
A phase I study of nimotuzumab ...... ced non-small-cell lung cancer
@en
type
label
A phase I study of nimotuzumab ...... ced non-small-cell lung cancer
@ast
A phase I study of nimotuzumab ...... ced non-small-cell lung cancer
@en
prefLabel
A phase I study of nimotuzumab ...... ced non-small-cell lung cancer
@ast
A phase I study of nimotuzumab ...... ced non-small-cell lung cancer
@en
P2093
P2860
P1476
A phase I study of nimotuzumab ...... ced non-small-cell lung cancer
@en
P2093
Jianchun Duan
Shuhang Wang
Tongtong An
Yuyan Wang
Zhijie Wang
P2860
P356
10.3978/J.ISSN.1000-9604.2016.02.07
P50
P577
2016-02-01T00:00:00Z